Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

[Investigation of Serum Macrophage Migration Inhibitor Factor (MIF) levels in patients with cutaneous leishmaniasis.].

Kozaci DL, Ertuğ S, Kavak T, Okyay P, Chikanza IC, Ertabaklar H.

Turkiye Parazitol Derg. 2005;29(3):145-8. Turkish.

2.

Candidate gene case-control and functional study shows macrophage inhibitory factor (MIF) polymorphism is associated with cutaneous leishmaniasis.

de Jesus Fernandes Covas C, Cardoso CC, Gomes-Silva A, Santos Oliveira JR, Da-Cruz AM, Moraes MO.

Cytokine. 2013 Jan;61(1):168-72. doi: 10.1016/j.cyto.2012.09.012. Epub 2012 Oct 13.

3.

Evidence that lipopolisaccharide may contribute to the cytokine storm and cellular activation in patients with visceral leishmaniasis.

Santos-Oliveira JR, Regis EG, Leal CR, Cunha RV, Bozza PT, Da-Cruz AM.

PLoS Negl Trop Dis. 2011 Jul;5(7):e1198. doi: 10.1371/journal.pntd.0001198. Epub 2011 Jul 12.

4.

Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.

Isidori AM, Kaltsas GA, Korbonits M, Pyle M, Gueorguiev M, Meinhardt A, Metz C, Petrovsky N, Popovic V, Bucala R, Grossman AB.

J Clin Endocrinol Metab. 2002 Apr;87(4):1834-40.

PMID:
11932327
5.

Increase in macrophage migration inhibitory factor levels in lacrimal fluid of patients with severe atopic dermatitis.

Kitaichi N, Shimizu T, Honda A, Abe R, Ohgami K, Shiratori K, Shimizu H, Ohno S.

Graefes Arch Clin Exp Ophthalmol. 2006 Jul;244(7):825-8. Epub 2005 Dec 6.

PMID:
16331484
6.

Migration-inhibitory factor gene-deficient mice are susceptible to cutaneous Leishmania major infection.

Satoskar AR, Bozza M, Rodriguez Sosa M, Lin G, David JR.

Infect Immun. 2001 Feb;69(2):906-11.

8.

Pilot study: elevated circulating levels of the proinflammatory cytokine macrophage migration inhibitory factor in patients with chronic spinal cord injury.

Stein A, Panjwani A, Sison C, Rosen L, Chugh R, Metz C, Bank M, Bloom O.

Arch Phys Med Rehabil. 2013 Aug;94(8):1498-507. doi: 10.1016/j.apmr.2013.04.004. Epub 2013 Apr 22.

PMID:
23618747
9.

High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease.

Hoshina T, Kusuhara K, Ikeda K, Mizuno Y, Saito M, Hara T.

Scand J Rheumatol. 2008 Nov-Dec;37(6):445-9. doi: 10.1080/03009740802144143.

PMID:
18720262
10.

Increased production of macrophage migration inhibitory factor by T cells in patients with IgA nephropathy.

Matsumoto K, Kanmatsuse K.

Am J Nephrol. 2001 Nov-Dec;21(6):455-64.

PMID:
11799262
11.

Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.

Lee TJ, Chun JK, Yeon SI, Shin JS, Kim DS.

Scand J Rheumatol. 2007 May-Jun;36(3):222-5.

PMID:
17657678
12.

Impact of counterbalance between macrophage migration inhibitory factor and its inhibitor Gremlin-1 in patients with coronary artery disease.

Müller II, Müller KA, Karathanos A, Schönleber H, Rath D, Vogel S, Chatterjee M, Schmid M, Haas M, Seizer P, Langer H, Schaeffeler E, Schwab M, Gawaz M, Geisler T.

Atherosclerosis. 2014 Dec;237(2):426-32. doi: 10.1016/j.atherosclerosis.2014.09.010. Epub 2014 Sep 30.

PMID:
25463068
13.

Assessment of macrophage migration inhibitory factor in humans: protocol for accurate and reproducible levels.

Sobierajski J, Hendgen-Cotta UB, Luedike P, Stock P, Rammos C, Meyer C, Kraemer S, Stoppe C, Bernhagen J, Kelm M, Rassaf T.

Free Radic Biol Med. 2013 Oct;63:236-42. doi: 10.1016/j.freeradbiomed.2013.05.018. Epub 2013 May 22.

PMID:
23707455
14.

Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis.

Matsumoto K, Maruyama N, Maruyama T, Ohnishi Y, Nonaka S, Inoshita A, Ito K, Kitajima S, Abe M, Satomura A, Fujita T.

Clin Exp Immunol. 2005 Feb;139(2):338-47.

15.

Increased production of macrophage migration inhibitory factor by PBMCs of atopic dermatitis.

Shimizu T, Abe R, Ohkawara A, Nishihira J.

J Allergy Clin Immunol. 1999 Sep;104(3 Pt 1):659-64.

PMID:
10482843
16.

Macrophage migration inhibitory factor is enhanced in acute coronary syndromes and is associated with the inflammatory response.

Müller II, Müller KA, Schönleber H, Karathanos A, Schneider M, Jorbenadze R, Bigalke B, Gawaz M, Geisler T.

PLoS One. 2012;7(6):e38376. doi: 10.1371/journal.pone.0038376. Epub 2012 Jun 5.

17.

Macrophage migration inhibitory factor is a potential inducer of endothelial progenitor cell mobilization after flap operation.

Grieb G, Piatkowski A, Simons D, Hörmann N, Dewor M, Steffens G, Bernhagen J, Pallua N.

Surgery. 2012 Feb;151(2):268-277.e1. doi: 10.1016/j.surg.2010.10.008. Epub 2010 Dec 30.

PMID:
21193209
18.

Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis.

Yamada G, Shijubo N, Takagi-Takahashi Y, Nishihira J, Mizue Y, Kikuchi K, Abe S.

Clin Immunol. 2002 Aug;104(2):123-7.

PMID:
12165273
19.

Urinary levels of macrophage migration inhibitory factor in patients with IgA nephropathy.

Matsumoto K, Kanmatsuse K.

Nephron. 2002 Oct;92(2):309-15.

PMID:
12218308
20.

Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation.

Toubai T, Shono Y, Nishihira J, Ibata M, Suigita J, Kato N, Ohkawara T, Tone S, Lowler KP, Ota S, Tanaka J, Asaka M, Reddy P, Imamura M.

Int J Lab Hematol. 2009 Apr;31(2):161-8. Epub 2007 Dec 12.

Supplemental Content

Support Center